T1	PrimaryOutcome 48 76	time to clinical improvement
T2	OutcomeDefinition 89 275	the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live discharge from the hospital, whichever came first
T3	OutcomeDefinition 612 1022	1, not hospitalized with resumption of normal activities; 2, not hospitalized, but unable to resume normal activities; 3, hospitalized, not requiring supplemental oxygen; 4, hospitalized, requiring supplemental oxygen; 5, hospitalized, requiring nasal high-flow oxygen therapy, noninvasive mechanical ventilation, or both; 6, hospitalized, requiring ECMO, invasive mechanical ventilation, or both; and 7, death
R1	DefinedAs Arg1:T1 Arg2:T2	
R2	DefinedAs Arg1:T1 Arg2:T3	
T4	OtherOutcome 1058 1123	clinical status as assessed with the seven-category ordinal scale
T5	TimeFrame 1124 1140	on days 7 and 14
R3	MeasuredAt Arg1:T4 Arg2:T5	
T6	OtherOutcome 1142 1151	mortality
T7	TimeFrame 1152 1161	at day 28
R4	MeasuredAt Arg1:T6 Arg2:T7	
T8	OtherOutcome 1167 1201	duration of mechanical ventilation
T9	OtherOutcome 1207 1247	duration of hospitalization in survivors
T10	OtherOutcome 1253 1306	the time (in days) from treatment initiation to death
T11	OtherOutcome 1474 1488	adverse events
T12	OtherOutcome 1521 1543	serious adverse events
T13	OtherOutcome 1549 1587	premature discontinuation of treatment
T14	OutcomeDefinition 1609 1722	classified according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0
R5	DefinedAs Arg1:T11 Arg2:T14	
